Cargando…

Applicability of Traditional In Vitro Toxicity Tests for Assessing Adverse Effects of Monoclonal Antibodies: A Case Study of Rituximab and Trastuzumab

Monoclonal antibody (mAb) therapeutics have a promising outlook within the pharmaceutical industry having made positive strides in both research and development as well as commercialisation, however this development has been hampered by manufacturing failures and attrition. This study explores the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kizhedath, Arathi, Wilkinson, Simon, Glassey, Jarka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640679/ https://www.ncbi.nlm.nih.gov/pubmed/31544882 http://dx.doi.org/10.3390/antib7030030

Ejemplares similares

Applicability of predictive toxicology methods for monoclonal antibody therapeutics: status Quo and scope
por: Kizhedath, Arathi, et al.
Publicado: (2016)

QSAR Implementation for HIC Retention Time Prediction of mAbs Using Fab Structure: A Comparison between Structural Representations
por: Karlberg, Micael, et al.
Publicado: (2020)

Normalisation of Multicondition cDNA Macroarray Data
por: Dawes, Nicola L., et al.
Publicado: (2007)

Virtual labs – love them or hate them, they are likely to be used more in the future
por: Glassey, Jarka, et al.
Publicado: (2020)

Perceptions and factors affecting the adoption of digital games for engineering education: a mixed-method research
por: Udeozor, Chioma, et al.
Publicado: (2023)

Development and characterization of an anti-rituximab monoclonal antibody panel
por: Tada, Minoru, et al.
Publicado: (2018)

The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
por: Lee, Carol M, et al.
Publicado: (2010)

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
por: Barbier, Liese, et al.
Publicado: (2019)

Drivers of immersive virtual reality adoption intention: a multi-group analysis in chemical industry settings
por: Toyoda, Ryo, et al.
Publicado: (2021)

Binding Affinity of Trastuzumab and Pertuzumab Monoclonal Antibodies to Extracellular HER2 Domain †
por: Cruz, Victor L., et al.
Publicado: (2023)

Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology
por: Khandelwal, Krishna, et al.
Publicado: (2023)

Expression Enhancement in Trastuzumab Therapeutic Monoclonal Antibody Production using Genomic Amplification with Methotrexate
por: Akbarzadeh-Sharbaf, Soudabeh, et al.
Publicado: (2013)

Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
por: Pierpont, Timothy M., et al.
Publicado: (2018)

Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
por: Shpilberg, O, et al.
Publicado: (2013)

Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2009)

In silico design, construction and cloning of Trastuzumab humanized monoclonal antibody: A possible biosimilar for Herceptin
por: Akbarzadeh-Sharbaf, Soudabeh, et al.
Publicado: (2012)

Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions
por: Krysko, Kristen M., et al.
Publicado: (2019)

Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
por: Papageorgiou, Sotirios G., et al.
Publicado: (2022)

Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumab
por: Butterfield, John T., et al.
Publicado: (2017)

Quality Control and Stability Studies with the Monoclonal Antibody, Trastuzumab: Application of 1D- vs. 2D-Gel Electrophoresis
por: Nebija, Dashnor, et al.
Publicado: (2014)

Effect of Microencapsulation Shear Stress on the Structural Integrity and Biological Activity of a Model Monoclonal Antibody, Trastuzumab
por: Pabari, Ritesh M., et al.
Publicado: (2011)

Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy
por: Marcinkowska, Monika, et al.
Publicado: (2018)

Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation
por: Ku, Terrance J.Y., et al.
Publicado: (2020)

Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab
por: Rabascall, Carlos X, et al.
Publicado: (2021)

Adverse Events of Monoclonal Antibodies Used for Cancer Therapy
por: Guan, Mei, et al.
Publicado: (2015)

Treatment of COVID-19 by monoclonal antibodies and the traditional Chinese medicine
por: Ling, Yuyan, et al.
Publicado: (2022)

Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3
por: Wang, Wei, et al.
Publicado: (2014)

Rituximab-related Severe Toxicity
por: Ghrenassia, E., et al.
Publicado: (2018)

Rituximab-Related Pulmonary Toxicity
por: Herishanu, Yair, et al.
Publicado: (2010)

Budget Impact Analysis of the Introduction of Rituximab and Trastuzumab Intravenous Biosimilars to EU-5 Markets
por: Jang, Minyoung, et al.
Publicado: (2020)

Case Report: Use of Obinutuzumab as an Alternative Monoclonal Anti-CD20 Antibody in a Patient With Refractory Immune Thrombocytopenia Complicated by Rituximab-Induced Serum Sickness and Anti-Rituximab Antibodies
por: Blase, Jennifer R., et al.
Publicado: (2022)

Severe hypoglycemia with trastuzumab: An unseen adverse event
por: Amrith, B. P., et al.
Publicado: (2019)

Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects
por: Zaza, Gianluigi, et al.
Publicado: (2014)

Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitised liposomes directed to cells by monoclonal antibody in vitro.
por: Morgan, J., et al.
Publicado: (1989)

Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma
por: Montraveta, Arnau, et al.
Publicado: (2014)

International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab
por: Prior, Sandra, et al.
Publicado: (2017)

Recurrent idiopathic membranous nephropathy in the renal allograft: successful treatment with the anti-CD20 monoclonal antibody rituximab
por: Ladino, Marco, et al.
Publicado: (2009)

A rapid method for relative quantification of N-glycans from a therapeutic monoclonal antibody during trastuzumab biosimilar development
por: Segu, Zaneer, et al.
Publicado: (2020)

Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study
por: Abad-Sazatornil, María Reyes, et al.
Publicado: (2021)

ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab
por: Agnolon, Valentina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pokafsh38tdavu25u33j84ltm9